Biomedical Microfluidics & Nanotechnology Lab
Our mission is to develop analytical tools and molecular biomarkers for quantitative analysis of dynamic and heterogeneous molecular processes underlying complex biological systems. Drawing on chemistry, molecular/cell biology, engineering, and materials science, we strive to advance quantitative biology and personalized medicine through technology innovation and translational research. For more details please visit our Research page.
We are inviting postdoctoral scholars, graduate and undergraduate students to join us. For details, please visit the Position page.
Our research is currently supported by the University of Kansas, National Cancer Institute (NCI) Innovative Molecular Analysis Technologies Program (IMAT), the J.R. & Inez Jay Fund, NIH/NIGMS K-INBRE, NIH COBRE Center for Molecular Analysis of Disease Pathways (CMADP), and NIH COBRE Center for Cancer Experimental Therapeutics (CCET).